New England Journal of Medicine· 2016Q1
Genomic Classification and Prognosis in Acute Myeloid Leukemia
- 4,402citations
- Q1SCImago
- 2016year
Short summary
A large-scale genomic analysis of 1540 acute myeloid leukemia (AML) patients has identified 11 distinct molecular subgroups, revealing that combinations of gene mutations, rather than single mutations, significantly impact disease progression and patient outcomes.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Hematology
HematologyMedicine